Barclays’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-2,625
Closed -$32K 4570
2013
Q3
$32K Sell
2,625
-38,633
-94% -$471K ﹤0.01% 3353
2013
Q2
$597K Buy
+41,258
New +$597K ﹤0.01% 2098